Johnson & Johnson has become the fourth pharmaceutical company to file a claim before federal court trials against several manufacturers and distributors of Cleveland, which is scheduled for later this month.
Johnson & Johnson has agreed to a $ 22.4 million settlement in Ohio that is believed to have fueled the opioid addiction crisis.
(AFP)
Johnson & Johnson said Tuesday they will pay $ 22.4 million to settle claims in two areas of Ohio.
J & J became the fourth pharmaceutical company to file a claim prior to a federal court trial against several Cleveland manufacturers and distributors scheduled for later this month.
The case is considered a lawsuit for more than 2,600 lawsuits by state and local governments pending throughout the country.
J & J said in a statement, "This agreement will allow the company to avoid resource demand and testing uncertainty as it continues to pursue meaningful advances to resolve the company's opioid crisis."
"The company recognizes that the opioid crisis is a complex public health challenge and is working to help communities and people in need," he added.
Consensus Pickling Liability
According to the U.S. Centers for Disease Control and Prevention, opioids died from 400,000 overdose in the United States from 1999 to 2017.
J & J, who previously sold Duragesic and Nucynta painkillers, said it was not responsible for the agreement.
The company will pay $ 10 million to Cuyahoga and Summit counties, reimburse $ 5 million in legal and other costs, and provide $ 5.4 million to nonprofits operating opioid-related programs in the county.
Mallinckrodt Plc completed a $ 24 million payment on Monday in the same two counties.
Endo International Plc and Allergan Plc also agreed with the two counties in August to avoid trial.
Remained defendants in a federal trial on October 21 included McKesson Corp, AmerisourceBergen, Cardinal Health, Teva Pharmaceutical Industries Ltd, Walgreens Boots Alliance Inc and Henry Schein Inc.
OxyContin manufacturer Purdue Pharmaceuticals LP under pressure in a lawsuit in September filed for bankruptcy protection.
Some plaintiffs' lawyers compared the opioid case with state lawsuits against the tobacco industry, resulting in a $ 265 billion settlement in 1998.
Earlier this year, the Oklahoma judge ordered Johnson & Johnson to pay $ 551 million a week to fuel the opioid epidemic by deceptively marketing addictive painkillers.
Purdue Pharma and Teva settled claims for $ 275 million and $ 88 million, respectively, by the Attorney General of Oklahoma.
Source: Reuters
Source Link : https://www.trtworld.com/business/j-j-settles-with-ohio-counties-to-tune-of-20-4m-ahead-of-opioid-trial-30279?utm_source=other&utm_medium=rss